ACRX AcelRx Pharmaceuticals Inc.
NewsSee all news
-
AcelRx Pharmaceuticals Announces Publication Analyzing Pooled Dosing and Efficacy Data on Sufentanil Sublingual 30 mcg Tablets
REDWOOD CITY, Calif., Nov. 13, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in
-
AcelRx Pharmaceuticals Reports Third Quarter 2019 Financial Results
REDWOOD CITY, Calif., Nov. 6, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use
-
AcelRx Pharmaceuticals to Present at Credit Suisse 28th Annual Healthcare Conference
REDWOOD CITY, Calif., Nov. 5, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the use in
-
AcelRx to announce third quarter 2019 results and provide an update on the company's business on Wednesday, November 6th, 2019
REDWOOD CITY, Calif., Oct. 28, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), a specialty pharmaceutical company, today announced that it will release third quarter financial results after market close
Drug Information
Drug catalyst information is displayed when you hover over / tap on the stage bar graph.
Latest News
-
AcelRx Pharmaceuticals Announces Publication Analyzing Pooled Dosing and Efficacy Data on Sufentanil Sublingual 30 mcg Tablets
REDWOOD CITY, Calif., Nov. 13, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in
-
AcelRx Pharmaceuticals Reports Third Quarter 2019 Financial Results
REDWOOD CITY, Calif., Nov. 6, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use
-
AcelRx Pharmaceuticals to Present at Credit Suisse 28th Annual Healthcare Conference
REDWOOD CITY, Calif., Nov. 5, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the use in
-
AcelRx to announce third quarter 2019 results and provide an update on the company's business on Wednesday, November 6th, 2019
REDWOOD CITY, Calif., Oct. 28, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), a specialty pharmaceutical company, today announced that it will release third quarter financial results after market close